ABCDEFGHIJKLMNOPQRSTUVWXYZAAAB
1
Study PI ContactLead analyst contactWhole-exome sequencingWhole-genome sequencingCovid-19 Host Genetic Initiative Case-Control DefinitionsOligo-asymptomatic subjectsAccess to patient blood tests? (yes/no)
2
NameEmailNameEmail
Number of samples
Mean depth
Number of samples
Mean depth
A2 Cases CountA2 Controls CountB2 Cases Count
B2 Controls Count
C2 Cases Count
C2 Controls Count
Additional INFO
3
Brent Richardsbrent.richards@mcgill.ca
Guillaume Butler-Laporte
guillaume.butler-laporte@mail.mcgill.ca--76230x75687275487326436Yes
4
Said Ismailsaismail@qf.org.qaHamdi Mbarekhmbarek@qf.org.qa1406030x601336070013360640
no for now but we are trying to get this data from CDC
5
PI1: Malak Abedalthagafimalthagafi@kacst.edu.saPI2: Manal Alaameryalaameryma@ngha.med.sa715100x21830x250425170425508425
yes, covid patients but not normal population
6
Miroslaw Kwasniewski
miroslaw.kwasniewski@umb.edu.pl
Pawel Olszewskipolszewski@imagene.me435100x--2141410433115425180All cases positive with qPCRNumbers in the table represent what we can reach for the first round of the analysis at the end of November. Succesively we want to reach 1000 WES of COVID-19 cases, different severity course (we will have clinical data) plus 254 population controls (1254 WES in total)
7
UC COVID-19 host genetics consortium
Dan Geschwind, Manish Butte, Bogdan Pasaniuc, Jonathan Sebat
jsebat@ucsd.eduBogdan Pasaniucbpasaniuc@mednet.ucla.edu220100x70030x
8
GEN-COVIDAlessandra Renierialessandra.renieri@unisi.itSimone Furinisimone.furini@unisi.it1178200x3388408783001178-300
9
Helix and Healthy Nevada Project Exome+ Covid-19 PhenotypesLiz Cirulliliz.cirulli@helix.comLiz Cirulliliz.cirulli@helix.com230003425441333noThis count is across all populations. As a population study, we have info about the lifestyles of people who were not infected or did not have symptoms, meaning we can enrich for exposed uninfected / asymptomatic as a helpful control
10
DeCOI cohortEva Schulte, Julien Gagneur, Kerstin Ludwig118
11
Swedish cohortHugo Zeberghugo.zeberg@ki.se
Guillaume Butler-Laporte
guillaume.butler-laporte@mail.macgill.ca200100x200200200yesICU COVID-19 patients (PCR-verified) from two University Hospitals in the Greater Stocholm Area
12
CHIRP (COVID-19 Host Immune Response Pathogenesis) StudySulggi Leesulggi.lee@ucsf.eduDavid Siegeldavid.siegel@ucsf.edu300100X100100100yes
We are currently enrolling; SF COVID rates are down but we are still enrolling weekly somehow. Inpatient banked samples with serial serum (to do corresponding cytokine work) is being used to track patients admitted to San Francisco General Hospital since April 2020 and we are now obtaining whole blood for DNA extraction prospectively (~5 samples a week rate currently). Sample colletion estimated to be complete ~ Feb or March 2020
13
Sinai_COVIDJoseph Buxbaumjoseph.buxbaum@mssm.eduLaura Sloofmanlaura.sloofman@mssm.eduTBD (soon) TBD (soon) TBD (soon) TBD (soon) TBD (soon) TBD (soon) TBD (soon) TBD (soon) TBD (soon) TBD (soon) Probably for most, have to check. We are currently deciding which samples to include in this analysis.
14
Columbia COVID-19 BiobankKrzysztof Kiryluk, David Goldsteinkk473@columbia.eduGundula Povysilgp2582@cumc.columbia.edu
1200 (available now)
100x1000-3000 (soon)30x1,233 (soon)9,000 (available now)2,331 (soon)
9,000 (available now)
3,000+ (soon)
9,000 (available now)
yesMulti-ethnic NYC-based cohort of severe cases hospitalized at Columbia and recruited at the peak of the pandemic (March-May 2020). N=1200 patients exome sequenced and available now, N=1000 samples undergoing WGS presently, depending on the funding may add additional 2000 in the near future.
15
INMUNGEN-CoV2
Anna Planas, Israel Fernández-Cadenas, Jordi Pérez-Tur
anna.planas@iibb.csic.esJordi Pérez-Turjpereztur@ibv.csic.es200TBD (soon)
100 (additional to the 200 WES)
Yes (for most)Multi-ethnic Spanish and latino with a few arabic and some Asian individuals.
16
Regeneron Genetics Center (UKB)45583850444334312684538352003453835
17
Penn Medicine BioBank (PMBB)Anurag Verma, Marylyn Ritchie, Daniel Raderanuragv@upenn.eduAnurag Vermaanuragv@upenn.edu
18
Transalpine Alliance for Covid GenomicsJacques Fellayjacques.fellay@epfl.chChristian ThorballChristian.Thorball@chuv.ch10030xnoICU COVID-19 patients without known risk factors
19
GEN-COVID - IDIS - Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
Antonio Salas (PI), Federico Martinon (PI)antonio.salas@usc.esAntonio Salas
antonio.salas@usc.es (secundary email address: antoniosalasellacuriaga@gmail.com)
896TBD (about 50)31 adults, 2 pediatric + 7 PIMS44 pediatric
68 adults, 4 pediatric + 3 PIMS
6 adults, 215 pediatric
40 adults, 3 pediatric
366 adults, 107 pediatric
All cases positive with qPCRAll are of European ancestry, as infered from genomics. We are now planning to do carry out WGS of a few severe cases and PIMS
20
Host genetic factors in COVID-19 patients in relation to disease susceptibility, disease severity and pharmacogenomics
Pajaree Chariyavilaskulpajaree.l@chula.ac.thChureerat Phokeawchureerat.phokaew@gmail.com2000yesAll are Thai patients
21
Genetics of host susceptibility to COVID-19.
Jamal Nasir, Nirmal Vadgama, Iaonnis Karakikes, Gaurav Harlalka,
Jamal Nasirjamal.nasir@northampton.ac.uk200100x00TBDTBDTBDTBDTBDTBDTBDprobablyWill include South Asians
22
POLISH COVID WGSPaweł Zawadzkipawel.zawadzki@mnm.bioPaweł Sztromwasserpawel.sztromwasser@mnm.bio57116811165111235111
23
FHoGIDPierre-Yves Bochudpierre-yves.bochud@chuv.chMathieu Quinodozmathieu.quinodoz@iob.ch230100x98100Probably for mostOnly europeans
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100